Frederick R Appelbaum
8PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 24, 2025
Prognostic impact of age and MDS-associated mutations in NPM1 -mutated AML.Vivian M Liu, Megan Othus, Jasmine Naru
|Jan 27, 2025
Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203.Megan Othus, Guillermo Garcia-Manero, Frederick R Appelbaum
|Dec 12, 2024
Relationship between donor source, pre-transplant measurable residual disease, and outcome after allografting for adults with acute myeloid leukemia.Corentin Orvain, Filippo Milano, Eduardo Rodríguez-Arbolí
|Oct 09, 2024
Offering patients a second chance: what is the minimum cure rate needed to justify allogeneic hematopoietic cell transplantation?Frederick R Appelbaum
|Mar 03, 2021
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial.Richard A Larson, Sumithra J Mandrekar, Lucas J Huebner
|May 26, 2018
Next-generation sequencing for measuring minimal residual disease in AML.Roland B Walter, Frederick R Appelbaum
Pageof 2
Frequent Collaborators
3 joint publications
Megan Othus
2 joint publications
Suravi Raychaudhuri
2 joint publications
Eliana Dietrich
2 joint publications
Brenda M Sandmaier
2 joint publications
Roland B Walter
1 joint publications
Paul J Martin
1 joint publications
Rainer F Storb
1 joint publications
Richard T Maziarz
1 joint publications
H Joachim Deeg
1 joint publications
Stephanie J Lee
